Toll Free: 1-888-928-9744

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Canada

Published: Jul 5, 2017 | Pages: 228 | Publisher: GlobalData | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Canada


GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Canada". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Canada. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Canada. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

In 2016, Canada population was approximately at 36.3 million. The Canadian pharmaceutical industry is the 10th largest market with a share of 2% of the global market. In 2015, pharmaceutical sales were estimated at $22.1 billion. This rose to about $22.6 billion in 2016 and is forecast to increase to $25 billion in 2021, at a CAGR of 2%. Patented drugs accounted for 61.8% of the total sales in 2015. The medical device market in Canada was worth $8.7 billion in 2009, which increased to $11 billion in 2016. It is expected to grow at a CAGR of 4.2% from $11.5 billion in 2017 to $13.5 billion in 2021. The main segments ophthalmic devices, orthopedic devices, drug delivery devices, in vitro diagnostics and healthcare IT will drive market growth.

These positive trends can primarily be attributed to - 
- Increasing awareness regarding early disease detection and diagnosis
- Advances in medical technology


The report provides information on the healthcare, regulatory, and reimbursement landscape in Canada, and includes - 
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Johnson & Johnson, Novartis, Teva, Apotex and Gilead) and profiles and SWOT analyses of the major players in the medical device market (Johnson & Johnson, Medtronic, Baxter, Fresenius and Sonova)
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Canadian healthcare market

Reasons To Buy

This report will enhance your decision-making capability by allowing you to - 
- Develop business strategies by understanding the trends shaping and driving the Canadian healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the Canadian healthcare market
 Table of Contents

1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 7

2 Executive Summary 9

3 Introduction 14
3.1 GlobalData Report Guidance 14

4 Overview of the Pharmaceutical and Medical Device Markets 15
4.1 Pharmaceutical Market 15
4.1.1 Market Overview 15
4.1.2 Pharmaceutical Imports and Exports 19
4.1.3 Supply Channels 20
4.1.4 Market Segments 21
4.1.5 Overview of Major Therapeutic Areas 25
4.1.6 Overview of Major Drug Classes 27
4.1.7 Major Players 29
4.2 Medical Device Market 62
4.2.1 Market Overview 62
4.2.2 Overview of Top Five Segments 65
4.2.3 Major Players 76
4.3 Market Drivers and Barriers 101
4.3.1 Drivers 101
4.3.2 Barriers 102

5 Market Access 104
5.1 Reimbursement and Payer Landscape 104
5.1.1 Overview of Healthcare System 104
5.1.2 Drug Reimbursement Process 105
5.1.3 Medical Device and Diagnostics Reimbursement Process 108
5.1.4 Overview of Insurance Providers 110
5.1.5 Patient Share in Healthcare Spending 112
5.1.6 Price Trend in Healthcare Services 113
5.1.7 Pricing Policies 115
5.2 Regulatory Landscape 116
5.2.1 Overview of Regulatory Agencies 116
5.2.2 Market Authorization Procedure for Pharmaceutical Products 118
5.2.3 Market Authorization Procedure for Medical Devices 123
5.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 126
5.2.5 Licensing Process for Pharmaceutical Exports and Imports 127
5.2.6 Intellectual Property Rights 128
5.2.7 Clinical Trial Regulations 131
5.2.8 Pharmacy Regulations 134
5.2.9 Labeling and Packaging Regulations 135

6 Country Analysis 137
6.1 Political Environment 137
6.1.1 Political Structure 137
6.1.2 Analysis of the Current Political Environment 139
6.1.3 Healthcare Policy Initiatives 140
6.2 Economic Landscape 142
6.3 Economic Indicators 146
6.3.1 Gross Domestic Product 146
6.3.2 Gross National Income 150
6.3.3 Inflation 152
6.3.4 Currency Exchange Rate 154
6.3.5 Foreign Direct Investment 155
6.3.6 Foreign Exchange Reserves 156
6.3.7 Trade Balance 157
6.3.8 General Government Structural Balance 159
6.3.9 General Government Net Debt 160
6.3.10 Major Industries 161
6.4 Demographics 163
6.4.1 Population 163
6.4.2 Urban-Rural Share 165
6.4.3 Distribution by Age Group 166
6.4.4 Birth Rate 168
6.4.5 Mortality 169
6.4.6 Causes of Mortality 170
6.4.7 Health Status by Gender and Age 171
6.4.8 Education and Literacy 179
6.4.9 Employment 181
6.4.10 Disease Burden 182
6.5 Healthcare Infrastructure 185
6.5.1 Healthcare Facilities 185
6.5.2 Healthcare Parameters 187
6.5.3 Environmental Health 190
6.5.4 Healthcare Personnel 193
6.6 Healthcare Expenditure 197
6.6.1 Overview 197
6.6.2 Public-Private Sector Share 200
6.6.3 Major Components of Healthcare Spending 201
6.6.4 Spending in Science and Technology Research and Development 203
6.7 Trade Associations 204
6.7.1 Canadian Pharmacists Association (CPhA) 204
6.7.2 Canadian Association of Professional Regulatory Affairs 204
6.7.3 Canadian Society for Hospital Pharmacists 204
6.7.4 Canadian Generic Pharmaceutical Association 204
6.8 Trade Fairs 205

7 Opportunities and Challenges 206
7.1 Opportunities 206
7.2 Challenges 206

8 Appendix 208
8.1 Abbreviations 208
8.2 Bibliography 213
8.3 Research Methodology 225
8.3.1 Coverage 226
8.3.2 Secondary Research 226
8.3.3 Forecasts 227
8.3.4 Expert Panel 227
8.4 Contact Us 227
8.5 Disclaimer 228

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global agricultural films market size is anticipated to reach USD 10.5 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing need to raise agricultural productivity, in order to meet surplus demand by growing population i


Global polymethyl methacrylate (PMMA) market size is likely to be valued at USD 11.65 billion by 2022; as per a new research report by Radiant Insights, Inc. Increasing spending on advertising & marketing for building strong brand equity and product


Global contact lenses market size is estimated to reach USD 12.5 billion by 2020, according to a new industry report by Radiant Insights, Inc. Growing number of ophthalmic disorder observed in global population especially children is likely to drive


Global Bio polyethylene terephthalate (PET) market size is likely to be valued at USD 12.6 billion by 2020; as per a new research report by Radiant Insights, Inc. Growing preference of biopolymers in numerous applications coupled with favorable gover


Global fumaric acid market size is anticipated to be valued at USD 764.8 million by 2020, as per a new research report by Radiant Insights, Inc. Growing processed food demand coupled with RTD (ready-to-drink) beverages consumption is expected to driv

Choose License Type
Single User - US $1995
Multi User - US $3990
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: sale[email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.